Konstantin Linnik, JD, PhD – Nutter McClennen & Fish LLP

USPTO Issues Guidance in View of Myriad and Prometheus

On March 4, 2014, the U.S. Patent and Trademark Office (USPTO) published the long-awaited Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products…more

|

The Myriad Decision: Has the Dust Settled Yet?

Six months ago, the United States Supreme Court shook up the biotechnology industry by ruling that genetic sequences are not patent eligible “simply because they have been isolated.” AMP v. Myriad Genetics, 569 U.S. 12-398 (June…more

|

The Myriad Ruling: 6 Points Every Biotech CEO Must Consider

Last week, the US Supreme Court issued a long-awaited decision in Myriad Genetics, which sent shockwaves through the very foundation of the biotech industry. The decision invalidated one of Myriad’s patents on mutated BRCA-gene …more

| Constitutional Law, Health, Intellectual Property, Privacy

Who Owns My Invention?

In a July 12, 2012 order, Suffolk Superior Court Justice Lauriat dismissed a lawsuit by urologist Dr. Grocela, asserting that his employer’s Intellectual Property (IP) policy as applied to him was an unfair restraint on trade…more

| Intellectual Property, Labor & Employment Law

Myriad Genetics Notches Another Legal Victory

Sept 6, 2012, Cancer Discover--Myriad Genetics of Salt Lake City, UT, can check off another legal victory on its BRCA1 and BRCA2 patent claims. On August 16, 2012, the U.S. Court of Appeals for the Federal Circuit in…more

| Health, Intellectual Property

PPACA: What’s Next For Life Sciences Companies

Law360, New York (August 24, 2012, 12:57 PM ET) -- Life sciences companies breathed a sigh of relief when the U.S. Supreme Court largely upheld the Patient Protection and Affordable Care Act (PPACA). After all, the PPACA will…more

| Antitrust & Trade Regulation, Health, Insurance, Intellectual Property

Federal Circuit Reaffirms (Again) Gene Patents in Myriad

On August 16, 2012, biotechnology patent owners breathed a short sigh of relief, as the US Court of Appeals for the Federal Circuit issued the highly anticipated decision in Association for Molecular Pathology v. Myriad…more

| Intellectual Property

The US Health Care Law: What’s Next for Stakeholders

In a widely publicized recent health care ruling, the Supreme Court largely upheld the Patient Protection and Affordable Care Act (ACA). The Court determined that the individual mandate is constitutional. However, the Court also…more

| Constitutional Law, Labor & Employment Law, Health, Intellectual...

USPTO Issues Patentability Guidelines Under Mayo v. Prometheus

On July 5, 2012, the United States Patent and Trademark Office published a memorandum to all patent examiners providing guidelines for examining process claims for patent eligibility in view of the Supreme Court decision Mayo v…more

| Intellectual Property

This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.